UCLA tests stem cell trick to end lifelong Anti-Rejection drugs for liver transplants
NCT ID NCT07269041
First seen Jan 04, 2026 · Last updated May 09, 2026 · Updated 21 times
Summary
This study tests a new approach to help liver transplant recipients stop taking toxic anti-rejection drugs for good. Twelve adults who received a liver from a living donor at least one year ago will get a donor stem cell infusion after a mild radiation and antibody treatment. The goal is to retrain the immune system to accept the liver as 'self,' so patients can live drug-free. Success could mean fewer side effects and a better quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCLA Health 200 Medical Plaza
RECRUITINGLos Angeles, California, 90095, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.